Eric Schadt is listed as an executive officer and director on 2 SEC Form D filings by 1 issuer between Mar 2026 and Jun 2026: 5D Patient Journey, Inc. (New Rochelle, NY — biotechnology — 2026; $5.46M reported sold to 5 investors).
What this means One deal on file with the SEC, filed Jun 2026. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Daniel Clark (1 shared filing) and Erick Dai (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Eric. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 1 SEC release, 7 bankruptcy cases matching the name listed in Key records below.
What this means 10 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Eric Schadt and found 2 differences: Form D filed 35 days after the first sale; Form D filed 40 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.